Hilversum, Netherlands

Jan-Hendrik Reinders

This inventor holds 1 USPTO granted patent. Top assignee: Solvay Pharmaceuticals, Gmbh. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan-Hendrik Reinders. Retrieved from https://idiyas.com/inventor/jan-hendrik-reinders

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan-Hendrik Reinders: Innovator in Pharmaceutical Chemistry

Introduction

Jan-Hendrik Reinders is a notable inventor based in Hilversum, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential.

Latest Patents

Reinders holds a patent for "Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives, - Compounds having fibrinogen receptor-antagonistic activity." This innovative work focuses on compounds that exhibit specific biological activities, which could have important implications in medical treatments.

Career Highlights

Jan-Hendrik Reinders is associated with Solvay Pharmaceuticals GmbH, where he has been involved in various research and development projects. His work has contributed to advancements in pharmaceutical formulations and therapeutic agents.

Collaborations

Throughout his career, Reinders has collaborated with esteemed colleagues such as Wolfgang Kehrbach and Uwe Schoen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Jan-Hendrik Reinders exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…